Jubilant Life Sciences Limited enters into Licensing Agreement with Gilead for Remdesivir, a potential therapy for Covid-19
12 May 2020 Jubilant Life Sciences Limited, an integrated global pharmaceutical and life sciences company, is pleased to announce that ...
Read moreDetails
